Literature DB >> 34473324

Testing for Thyroid Peroxidase and Antineuronal Antibodies in Depression and Schizophrenia.

Johann Steiner1,2,3, Winfried Stoecker4, Bianca Teegen4, Henrik Dobrowolny5,6, Gabriela Meyer-Lotz5,6, Katrin Borucki7, Paul C Guest8, Hans-Gert Bernstein5,6.   

Abstract

Dietary interventions and physical exercise may improve some symptoms in mental illnesses such as major depression and schizophrenia. Hashimoto's thyroiditis is a known risk factor for these conditions and is marked by the presence of circulating antibodies to thyroid peroxidase (TPO) and thyroglobulin (TG). This chapter presents a protocol to determine if patients with major depression or schizophrenia contain high circulating levels of these antibodies relative to healthy controls. We also describe a procedure testing for the presence of other circulating biomarkers related to brain function, including antibodies directly related to neuronal function. This analysis was performed by screening biochip mosaics of frozen tissue sections and transfected HEK293 cells expressing target antigens using patient and control sera. Finally, we describe a correlation analysis of these markers with symptom scores at baseline and after 6 weeks treatment of the patients using antipsychotics or antidepressants as appropriate.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Depression; Hashimoto thyroiditis; Mental disorder; Neuronal antibodies; Psychiatric symptom scores; Schizophrenia

Mesh:

Substances:

Year:  2022        PMID: 34473324     DOI: 10.1007/978-1-0716-1558-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions.

Authors:  Mark G A Opler; Christian Yavorsky; David G Daniel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

Review 2.  Global Burden of Disease and the Impact of Mental and Addictive Disorders.

Authors:  Jürgen Rehm; Kevin D Shield
Journal:  Curr Psychiatry Rep       Date:  2019-02-07       Impact factor: 5.285

3.  Unusual case of anti-N-methyl-D-aspartic acid-receptor (NMDA-R) encephalitis and autoimmune polyglandular syndrome (APS).

Authors:  Simona Frunza-Stefan; Hilary B Whitlatch; Gautam G Rao; Rana Malek
Journal:  BMJ Case Rep       Date:  2018-05-02

Review 4.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

5.  Autoantibody-Mediated Encephalitis.

Authors:  Klaus-Peter Wandinger; Frank Leypoldt; Ralf Junker
Journal:  Dtsch Arztebl Int       Date:  2018-11-05       Impact factor: 5.594

Review 6.  Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Front Immunol       Date:  2017-05-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.